医学会议分类导航
 
 
领域国际医学会议网公众号
 
首页  
2024年第8届世界血管通路大会
     
 

◆ 会议时间:2024年4月17-19日
◆ 会议地点:捷克 布拉格

 

◆ 会议简介:

第8届世界血管通路大会(WoCoVa2024)将于2024年4月17-19日在捷克布拉格举行。

WoCoVA(世界血管通路大会)始于2009年,是一个在荷兰注册的非营利组织。WoCoVA在世界各地组织研讨会和会议,重点关注血管通路方面,旨在分享知识并将血管通路技术提升到更高水平。WoCoVA汇集了世界各地血管通路领域宣的专业人士,会议重点介绍有关血管通路的新问题新观点、技术进步、循证实践,以及提供一个与经验丰富的专业人士进行交流的机会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com).

8th World Congress on Vascular Access (WoCoVA2024)
Date: 17-19 April 2024
Venue: Prague Congress Centre, Prague, Czech Republic

GloVANet (Global Vascular Access Network) is pleased to announce that the 8th WoCoVA will take place from Wednesday 17 to Friday 19 April 2024 in Prague, Czech Republic.

The WoCoVA congress, organized by GloVANet, is the biennial multidisciplinary and multi-professional high scientific event on all aspects of vascular access, including sharing experiences and learnings about future trends and innovations.

The 3-day congress will have presentations from highly renowned vascular access specialists from all over the world. Many producers and distributers will present and demonstrate their latest products in the exhibition area.

 

摘要征文投稿:

Abstract Submission deadline: 7 January 2024, 23:59 CET

Submit your abstract here

 

RULES FOR SUBMISSION

Please read the submission rules before submitting an abstract.

  • Abstracts must be submitted online via de website only. Abstracts submitted by email will not be accepted.
  • Presentation Type: Abstracts may be submitted for oral (10 minutes presentation) or e-poster presentation (The Scientific Committee will determine whether the abstract will be accepted for presentation or e-poster).
  • Abstracts must be received by the announced deadline. Abstracts received after the deadline (7 January 2024) will not be considered.

Limitations:

  • The same person may submit up to 4 abstracts regardless of presenting author.
  • The same person may serve as presenting author on up to 4 abstracts.
  • Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by the latest 10 March 2024 will be scheduled for presentation and included for publication.
  • Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Congress publications.
  • The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
  • Previously presented / Published policy: Abstracts must be original and must not have been published or presented at any other prior meeting. If, however, the abstract to be presented is on a topic you have used before, but now have developed a new poster or presentation with a varied viewpoint (or focused on a different aspect of the research) then you are welcome to submit the abstract.
  • Abstracts must be submitted in English.
  • Disclosure of ‘Conflicts of Interest:’ Abstract submitters will be required to disclose any conflict of interests in the submission form.
  • Instructions for preparation of presentations and e-posters will be made available on the Congress website.

GUIDELINES FOR SUBMISSION

Before you begin, please prepare the following information:

  • Presenting author’s contact details:
    – Full first and family name(s)
    – Email address
    – Affiliation details: department, institution / hospital, city, state (if relevant), country
    – Phone number
  • Author and co-authors’ details
  • Presentation preference: Oral or e-Poster ​
  • Abstract title – Maximum 25 words. Use capital letters only for the first word, abbreviations, and names.
  • Abstract text – limited to 300 words, including acknowledgements. Please note: word count is affected when tables are included.
  • Type of abstract– You can select between Scientific, Educational or Experience abstract.
  • Images– The maximum file size of each image is 500 KB. You may upload images in JPG, GIF or PNG format.
  • Abstracts should clearly state:
        Background and objective
        Methods
        Results
        Conclusions 
  • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
  • Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
  • Submissions may not contain patient names, hospital ID numbers or other identifying information.
  • The submission allows you to adapt the abstract until the deadline for abstract submission (7 January 2024).
  • Click on ‘Confirm and submit’ at the end of the process to submit your abstract.
  • You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
  • Please contact us if you have not received confirmation that your abstract has been submitted.
  • Please do not submit multiple copies of the same abstract.

ABSTRACT SUBMITTERS' DECLARATION

During abstract submission you will be asked to confirm that you agree to the following:

  1. I confirm that I previewed this abstract, and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after the close of s submission (7 January 2024).
  2. Submission of the abstract constitutes the consent of all authors to publication (e.g., Congress website, program, other promotions, etc.)
  3. The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the “Content“) to WoCoVA, nor the publication of any such Content by WoCoVA, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.
  4. The Abstract Submitter grants WoCoVA the license and right to use, reproduce, publish, translate, distribute, and display the Content or any part thereof, in any manner and on any platform or media whatsoever, in WoCoVA’s absolute discretion, on a royalty-free, perpetual, irrevocable nonexclusive basis.
  5. I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.
  6. I understand that the presenting author must be a registered participant.
  7. WoCoVA reserve the right to remove from publication and/or presentation an abstract which does not comply with the above.
  8. I confirm to have received the consent of all authors for the processing of their contact details by WoCoVA.

 


 

注册费:

Registration fees

Full registration:

Early bird registration:  590 Euro (until 15 December 2023)
Standard registration: 690 Euro (Until 11 March 2024)
Late registration: 790 Euro (12 March till 19 April 2024)

Student registration

Standard registration: 440 Euro

 

Included in the registration fee

  • Full access to the scientific sessions and exhibition
  • Admission to the industry sponsored symposia
  • Coffe/tea and lunch during congress days
  • Congress bag with the final program and scientific material 
  • Certificate of Attendance
  • Name badge
  • Free city transportation pass

 

 

◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。

 
 
※相关服务※
会议注册服务:30美金起/人/次(服务费)+ 会议注册费(按官方规定收取,注册类别请咨询客服);
出境签证服务:1650元人民币/人/次(美国,含签证费),其它国家咨询客服;
大会投稿服务:30美金/人/次,官方收取费用另计(如有);
会员申请服务:30-100美金/人/次;

团组参会、行程定制,以及需要其它服务(如接送机等),请直接联系客服。


 
咨询报名:
李老师
400-089-1003(微信扫描右侧二维码咨询)
 
 
领域国际医学会议网——专注专业的国际医学会议服务商,专业服务医学相关群体!
 
  领域国际医学会议网介绍/联系  
版权所有:领域国际医学会议网 未经许可禁止复制转载摘录镜像本站任何内容! 隐私政策/版权/免责声明 | 联系我们